文献速递介入妇产影像DSAMR

首次与再次子宫动脉栓塞治疗症状性子宫肌瘤的比较

First Versus Second Uterine Artery Embolization for Symptomatic Leiomyoma.
PubMed 文献 · AJR Am J Roentgenol · 2017-06-22

单机构回顾性研究比较再次与首次子宫动脉栓塞治疗症状性子宫肌瘤的结局,首次组423例、再次组11例;再次组术后增强MRI肿瘤梗死率显著更低(69.8% vs 96.8%),1年子宫体积缩小率亦更低(33.4% vs 46.9%),再次栓塞有效但劣于首次。

要点

  • 再次子宫动脉栓塞后增强MRI肿瘤梗死率显著低于首次栓塞(69.8% vs 96.8%)。
  • 再次栓塞1年子宫体积缩小率显著低于首次栓塞(33.4% vs 46.9%)。
  • 再次栓塞时侧支血管更多(1.1/例 vs 0.23/例),除一支外子宫动脉均再通。

核心结论

  • 再次子宫动脉栓塞有效,但增强MRI显示肿瘤梗死更少、1年子宫体积缩小率更低,劣于首次栓塞。

研究设计与样本

  • 单机构回顾性研究,1997年12月至2016年5月连续登记,首次栓塞423例、再次栓塞11例,以术后增强MRI全部肿瘤组织梗死为主要终点。

关键影像表现/征象

  • 再次栓塞组除一支子宫动脉外所有子宫动脉均再通。
  • 再次栓塞时观察到更多侧支血管(1.1/例 vs 0.23/例,p=0.043)。

诊断标准与关键数值

  • 主要终点为术后增强MRI所见全部肿瘤组织梗死;再次栓塞组肿瘤梗死率69.8±33.9% vs 首次栓塞组96.8±9.0%(p=0.025)。
  • 校正可能混杂因素后梗死率差异仍显著(p<0.001),首次或再次手术与肿瘤梗死率显著相关(p<0.001)。
  • 术后1年子宫体积缩小率再次栓塞组33.4±18.1% vs 首次栓塞组46.9±16.6%(p=0.008)。
  • 其他1年结局两组间无显著差异。

临床应用与阅片要点

  • 再次栓塞术前应评估子宫动脉再通及侧支血管情况,后者在再次栓塞时更多见。
  • 术后增强MRI可用于评估肿瘤梗死程度,再次栓塞者梗死率可能较低。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to compare the outcomes of second uterine artery embolization (UAE) with those of first UAE for symptomatic uterine leiomyoma.

MATERIALS AND METHODS: In this single-institution retrospective study, between December 1997 and May 2016 first UAE was performed on 423 consecutively registered patients and second UAE on 11 consecutively registered patients to treat leiomyoma. The primary endpoint was infarction of all tumor tissue as seen at postprocedural contrast-enhanced MRI. The secondary endpoints were angiographic findings, embolization, MRI, and clinical outcomes 1 year after UAE. The outcomes were compared between the two groups. Multivariable linear regression analysis was performed to assess independent correlations with tumor infarction.

RESULTS: Most of the baseline demographic features and technical outcomes in the two groups were similar. In the second UAE group, all but one uterine artery was reopened. More collateral vessels were observed at the second UAE (1.1/patient versus 0.23/patient, p = 0.043). Contrast-enhanced MRI after UAE revealed that the tumor infarction rate was significantly lower in the second UAE group (69.8 ± 33.9% vs 96.8 ± 9.0%, p = 0.025). The difference remained significant after adjustments for possible confounders (p < 0.001). Whether UAE was a first or a second procedure was significantly associated with tumor infarction rate (p < 0.001). The uterine volume reduction rate 1 year after UAE was significantly lower in the second UAE group (33.4 ± 18.1% versus 46.9 ± 16.6%, p = 0.008). No other 1-year outcomes were significantly different between the groups.

CONCLUSION: Second UAE was effective but inferior to first UAE in that it resulted in less tumor infarction at contrast-enhanced MRI and had a lower uterine volume reduction rate.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Katsumori T, Miura H, Asai S, et al. First Versus Second Uterine Artery Embolization for Symptomatic Leiomyoma. AJR Am J Roentgenol. 2017. PMID: 28639830. doi:10.2214/AJR.16.17672

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。